Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Temocillin in ESBL/AmpC Urinary Tract Infections
NCT02681263Phase 4Unknown
- Sponsor
- CHU Grenoble Alpes
- Start
- Apr 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of temocillin in urinary tract infection (UTI), sponsored by CHU Grenoble Alpes. Primary endpoint: Microbiological efficacy at Test of Cure. Status: unknown.
02
Drugs
temocillin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02681263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02681263.